全文获取类型
收费全文 | 3825676篇 |
免费 | 285677篇 |
国内免费 | 6279篇 |
专业分类
耳鼻咽喉 | 54781篇 |
儿科学 | 125684篇 |
妇产科学 | 106841篇 |
基础医学 | 553265篇 |
口腔科学 | 111112篇 |
临床医学 | 344907篇 |
内科学 | 729813篇 |
皮肤病学 | 84020篇 |
神经病学 | 305937篇 |
特种医学 | 146525篇 |
外国民族医学 | 1180篇 |
外科学 | 578284篇 |
综合类 | 87801篇 |
现状与发展 | 13篇 |
一般理论 | 1494篇 |
预防医学 | 302596篇 |
眼科学 | 90924篇 |
药学 | 285904篇 |
10篇 | |
中国医学 | 7372篇 |
肿瘤学 | 199169篇 |
出版年
2018年 | 40394篇 |
2017年 | 30904篇 |
2016年 | 34425篇 |
2015年 | 39171篇 |
2014年 | 55260篇 |
2013年 | 84021篇 |
2012年 | 114439篇 |
2011年 | 121845篇 |
2010年 | 72574篇 |
2009年 | 68591篇 |
2008年 | 114778篇 |
2007年 | 121909篇 |
2006年 | 123192篇 |
2005年 | 119890篇 |
2004年 | 115868篇 |
2003年 | 111031篇 |
2002年 | 108544篇 |
2001年 | 168026篇 |
2000年 | 173272篇 |
1999年 | 146962篇 |
1998年 | 43161篇 |
1997年 | 38384篇 |
1996年 | 38159篇 |
1995年 | 36217篇 |
1994年 | 33745篇 |
1993年 | 31924篇 |
1992年 | 117541篇 |
1991年 | 114796篇 |
1990年 | 112266篇 |
1989年 | 108722篇 |
1988年 | 100750篇 |
1987年 | 99102篇 |
1986年 | 94114篇 |
1985年 | 90449篇 |
1984年 | 68009篇 |
1983年 | 58242篇 |
1982年 | 34718篇 |
1981年 | 31089篇 |
1979年 | 64060篇 |
1978年 | 45365篇 |
1977年 | 38037篇 |
1976年 | 36222篇 |
1975年 | 39048篇 |
1974年 | 47458篇 |
1973年 | 45565篇 |
1972年 | 42675篇 |
1971年 | 40134篇 |
1970年 | 37337篇 |
1969年 | 35391篇 |
1968年 | 32695篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Irritable bowel syndrome and health-related quality of life: a population-based study in Calgary, Alberta. 总被引:3,自引:0,他引:3
Feng Xiao Li Scott B Patten Robert J Hilsden Lloyd R Sutherland 《Journal canadien de gastroenterologie》2003,17(4):259-263
BACKGROUND: Little is known about the health-related quality of life (HRQOL) of nonclinical samples of people with irritable bowel syndrome (IBS) in Canada. In a pilot survey, the impact of IBS on HRQOL using a population-based, urban sample was examined. METHODS: A random sample of Calgary residents (18 years of age or older), selected by random digit dialing (n=1521), completed a structured questionnaire including ROME II Criteria and Medical Outcomes Study Short-Form 12-Item Health Survey, version 2 (SF-12v2). The mean scale and summary scores of SF-12v2 for those who did and did not meet ROME II criteria and for those who met ROME II criteria with and without visiting a physician in past three months were determined and compared using multiple regression analyses. RESULTS: Of the 951 households successfully contacted, 590 (62%) were willing to participate, of which 437 (74%) individuals were recruited. One hundred ten IBS cases (81 of which were women) and 327 non-IBS controls (180 of which were women) were identified. All of the eight mean scale scores and the two mean summary scores were significantly lower in people with IBS than in those without, whether or not adjusting for demographics. Forty-four of the 110 IBS cases (40%) sought medical help. Significantly lower mean physical component score and three scale scores (general health, social functioning and role physical) were found in those who sought medical help than in those who did not. CONCLUSIONS: People with IBS experience significant impairment in HRQOL, including both physical and mental well-being. People with IBS who seek medical help report worse physical health than those who do not, but their mental health is no different. 相似文献
992.
Prevalence of vitamin D depletion among morbidly obese patients seeking gastric bypass surgery 总被引:5,自引:0,他引:5
Arthur M. Carlin M.D. D. Sudhaker Rao MB B.S. F.A.C.P. F.A.C.E. Ali M. Meslemani M.D. Jeffrey A. Genaw M.D. Nayana J. Parikh Shiri Levy M.D. Arti Bhan M.D. Gary B. Talpos M.D. 《Surgery for obesity and related diseases》2006,2(2):696-103
BACKGROUND: Abnormalities in calcium and vitamin D metabolism have been reported after bariatric surgery. The purpose of this study was to evaluate vitamin D nutritional status among morbidly obese patients before gastric bypass surgery. METHODS: We prospectively studied 279 morbidly obese patients seeking gastric bypass surgery for vitamin D nutritional status as assessed by serum 25-hydroxyvitamin D level. In addition, serum samples were analyzed for calcium, alkaline phosphatase (AP), intact parathyroid hormone (PTH), and 1,25-dihydroxyvitamin D. RESULTS: Mean patient age was 43 +/- 9 years; 87% of the study patients were women, and 72% were white. Serum calcium and AP levels were normal in 88% and 89% of the patients, respectively. Vitamin D depletion, defined as serum 25-hydroxyvitamin D level 相似文献
993.
Mohammad K. Jamal M.D. Eric J. DeMaria M.D. Jason M. Johnson D.O. Brennan J. Carmody M.D. Luke G. Wolfe M.S. John M. Kellum M.D. Jill G. Meador R.N. 《Surgery for obesity and related diseases》2006,2(2):417-127
BACKGROUND: Preoperative dietary counseling (PDC) before bariatric surgery is mandated by a growing number of insurance payers. Their claim is that PDC improves outcomes and postoperative compliance. We compared outcomes of GBP patients undergoing a mandatory 13 weeks of PDC (n = 72) to a contemporaneous group of patients with no such requirement (no-PDC; n = 252) who underwent operation between January 2000 and December 2002. METHODS: The PDC and no-PDC groups were characterized by similar male:female ratios (1:4 vs 1:4.6), mean age (42 years), mean body weight (324 lb vs 309 lb), and mean body mass index (BMI) (52 kg/m2 vs 50 kg/m2). The PDC group had a higher incidence of obstructive sleep apnea compared with the no-PDC group (41% vs 28%; P < .04) but otherwise the two groups had similar incidences of obesity-related comorbidities. The presurgery dropout rate was 50% higher in the PDC group than in the no-PDC group (28% vs 19%; P < .05). RESULTS: At 1 year follow-up, the no-PDC patients had a statistically greater percentage excess weight loss (67% vs 60%; P < .0001), lower BMI (32 vs 35; P < .015), and lower body weight (197 vs 218; P < .01). Resolution of major comorbidities, complication rates, 30-day postoperative mortality, and postoperative compliance with follow-up were similar in the two groups. CONCLUSIONS: The data demonstrate that insurance-mandated PDC is an obstacle to patient access for surgical treatment of severe obesity and has no impact on weight loss outcome or postsurgical compliance. PDC should be abandoned by the insurance industry. 相似文献
994.
Invasive Fungal Infections in Low-Risk Liver Transplant Recipients: A Multi-Center Prospective Observational Study 总被引:4,自引:0,他引:4
P. G. Pappas D. Andes M. Schuster S. Hadley J. Rabkin R. M. Merion C. A. Kauffman C. Huckabee G. A. Cloud W. E. Dismukes A. W. Karchmer 《American journal of transplantation》2006,6(2):386-391
Prevention of invasive fungal infections (IFIs) in orthotopic liver transplant (OLT) recipients utilizing postoperative systemic antifungal prophylaxis, typically with fluconazole, is justified among those at high risk for IFI. Use of postoperative antifungal prophylaxis for low-risk OLT recipients is widely practiced but not universally accepted nor supported by data. We conducted a prospective observational study among 200 OLT recipients who were at low risk for IFI and did not receive postoperative antifungal prophylaxis. Patients were considered low risk if they had =1 of the following conditions: choledochojejunostomy anastomosis; retransplantation; intra-operative administration of >/=units of 40 blood products or return to the operating room for intra-abdominal bleeding; return to the operating room for anastomotic leak or vascular insufficiency; preoperative serum creatinine of >/=2 mg/dL; and perioperative Candida colonization. Patients were followed 100 d post-transplantation for evidence of IFI. Of 193 eligible patients, 7 (4%) developed an IFI. Three (2%) IFIs were due to Candida spp. and potentially preventable by standard fluconazole prophylaxis. Three patients developed invasive aspergillosis; one developed late onset disseminated cryptococcosis. Liver transplant recipients at low risk for IFI can be identified utilizing pre-determined criteria, and post-transplantation antifungal prophylaxis can be routinely withheld in these patients. 相似文献
995.
H. Johansson M. Goto A. Siegbahn G. Elgue O. Korsgren B. Nilsson 《American journal of transplantation》2006,6(2):305-312
The instant blood-mediated inflammatory reaction (IBMIR) is triggered in clinical islet transplantation when human pancreatic islets come in contact with blood and may explain the initial tissue loss associated with this procedure. Low molecular weight dextran sulfate (LMW-DS; MM 5000), today available for clinical use, inhibits both complement and coagulation activation. In a tubing loop model, LMW-DS at concentrations ranging from 0.01 to 1 g/L showed a dose-dependent inhibition of IBMIR with an inhibition of coagulation and complement activation and less consumption of platelets and other blood cells. In blood or plasma APTT was demonstrated to be an excellent method for monitoring the LMW-DS concentration both in vitro and in vivo in a nonhuman primate model. The toxicity was assessed using a glucose challenge test and the pharmacokinetics was tested in the nonhuman primate model. Here, we present a tentative protocol for using LMW-DS in clinical islet transplantation. 相似文献
996.
Early micromotion of implant components and periprosthetic bone loss in patients undergoing total knee arthroplasty are thought
to contribute to late aseptic loosening. In the pursuit of longer implant survival, the administration of bisphosphonates
may be advocated as a means to buffer implants against microinstability and periprosthetic bone loss. A bibliographic search
identified one metaanalysis and two randomised controlled trials dealing with this topic. Current evidence supports the hypothesis
that the inhibiting effects of bisphosphonates on bone resorption reduce implant micromotion and periprosthetic bone loss
at the one-year follow-up. Tested bisphosphonates include clodronate, pamidronate and alendronate. However, a decline in periprosthetic
BMD is observed at the three-year follow-up following a sixmonth course of bisphosphonate administration. Length of follow-up
in available studies is currently too short to determine whether bisphosphonates increase the longevity of implants. Furthermore,
the optimal dose, modality and length of bisphosphonate administration have yet to be determined. 相似文献
997.
998.
Veatch's Proposal May Not Work 总被引:1,自引:1,他引:0
999.
A. Nakao H. Toyokawa A. Tsung M. A. Nalesnik D. B. Stolz J. Kohmoto A. Ikeda K. Tomiyama T. Harada T. Takahashi R. Yang M. P. Fink K. Morita A. M. K. Choi N. Murase 《American journal of transplantation》2006,6(10):2243-2255
Carbon monoxide (CO), a byproduct of heme catalysis, was shown to have potent cytoprotective and anti-inflammatory effects. In vivo recipient CO inhalation at low concentrations prevented ischemia/reperfusion (I/R) injury associated with small intestinal transplantation (SITx). This study examined whether ex vivo delivery of CO in University of Wisconsin (UW) solution could ameliorate intestinal I/R injury. Orthotopic syngenic SITx was performed in Lewis rats after 6 h cold preservation in control UW or UW that was bubbled with CO gas (0.1-5%) (CO-UW). Recipient survival with intestinal grafts preserved in 5%, but not 0.1%, CO-UW improved to 86.7% (13/15) from 53% (9/17) with control UW. At 3 h after SITx, grafts stored in 5% CO-UW showed improved intestinal barrier function, less mucosal denudation and reduced inflammatory mediator upregulation compared to those in control UW. Preservation in CO-UW associated with reduced vascular resistance (end preservation), increased graft cyclic guanosine monophosphate levels (1 h), and improved graft blood flow (1 h). Protective effects of CO-UW were reversed by ODQ, an inhibitor of soluble guanylyl cyclase. In vitro culture experiment also showed better preservation of vascular endothelial cells with CO-UW. The study suggests that ex vivo CO delivery into UW solution would be a simple and innovative therapeutic strategy to prevent transplant-induced I/R injury. 相似文献
1000.
H. Newell J. D. Smith P. Rogers E. Birks A. J. Danskine R. E. Fawson M. L. Rose 《American journal of transplantation》2006,6(7):1712-1717
Implantation of left ventricular assist devices (LVAD) is associated with HLA antibody sensitization. The objective of this study was to determine the specificity of antibodies produced by LVAD recipients using a combination of ELISA, Luminex and microcytotoxicity assays. Fifty-one LVAD patients were studied, from 44 to 838 days post-implantation. No patient developed HLA antibodies, although 24 produced IgG antibodies detectable in both ELISA and Luminex assays. These antibodies manifest as positive reactions with class I and class II wells of the ELISA and also blank wells. In Luminex assays, they produce high MFI readings with the negative control beads. Antibodies were detected 18 to 228 days after implantation. This reactivity was found to be directed against bovine serum albumin (BSA), commonly used to block non-specific binding in ELISA and Luminex assays; absorption of sera with BSA-coated beads completely abrogated reactivity in all solid phase assays, but did not eliminate anti-HLA antibodies in control sera. Ten of the 24 patients have proceeded to transplantation, with a 1-year graft survival of 69%. In conclusion, it appears that implantation of LVADS disrupts immunoregulatory pathways leading to production of anti-albumin antibodies. These can be misinterpreted as anti-HLA antibodies in solid phase assays. 相似文献